SKI Market

Indian Indices

Nifty

24,578.35 -346.35
(-1.39%)

Sensex

81,148.22 -1,281.68
( -1.55%)

Bank Nifty

54,940.85 -442.00
( -0.80%)

Nifty IT

37,354.60 -927.95
( -2.42%)

Global Indices

Nasdaq

42,424.12 1,153.74
(2.80%)

Dow Jones

5,865.06 184.15
(3.24%)

Hang Seng

38,283.51 639.25
(1.70%)

Nikkei 225

8,602.92 -2.06
(-0.02%)

Forex

USD-INR

85.41 0.03
(0.03%)

EUR-INR

96.03 -0.26
(-0.27%)

GBP-INR

113.57 0.08
(0.07%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

139.278683

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

66.6

1119.1

EPS(TTM)

Face Value()

Div & Yield %

28.52

Back

TMT (I) reports standalone net loss of Rs 0.07 crore in the December 2024 quarter

Feb 14,2025

Net Loss of TMT (I) reported to Rs 0.07 crore in the quarter ended December 2024 as against net loss of Rs 0.08 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.

24,578.35 -346.35 (-1.39%)

81,148.22 -1,281.68 ( -1.55%)

54,940.85 -442.00 ( -0.80%)

37,354.60 -927.95 ( -2.42%)

42,424.12 1,153.74 (2.80%)

5,865.06 184.15 (3.24%)

38,283.51 639.25 (1.70%)

8,602.92 -2.06 (-0.02%)

85.41 0.03 (0.03%)

96.03 -0.26 (-0.27%)

113.57 0.08 (0.07%)

0.59 0.00 (-0.40%)